Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for ARDS Associated with COVID-19 Read more
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines Read more
VBI Vaccines Announces Tie-up To Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS, and MERS Read more
AstraZeneca’s Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis Read more
Altimmune And The University Of Alabama At Birmingham To Collaborate On Development Of Single-Dose, Intranasal COVID-19 Vaccine Read more
Noveome Launches Program to Evaluate ST266 for the Treatment of the Severe Inflammatory Response Associated with COVID-19 Read more